TheNote.app
Sign In
Sign Up
RSS STAT | Reporting from the frontiers of health and medicine
STAT+: Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
A CRISPR-augmented stem cell transplant has shown preliminary evidence that it can delay relapse in some cancer patients.
www.statnews.com
www.statnews.com